The DOI matches its Crossref record; 89 of the 90 references it cites were found in a registry or an index.
Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis
Open accessAbstract
Inflammation in the brain is a prominent feature in Alzheimer's disease (AD). Recent studies suggest that chronic inflammation can be a consequence of failure to resolve the inflammation. Resolution of inflammation is mediated by a family of lipid mediators (LMs), and the levels of these specialized pro-resolving mediators (SPMs) are reduced in the hippocampus of those with AD. In the present study, we combined analysis of LMs in the entorhinal cortex (ENT) from AD patients with in vitro analysis of their direct effects on neurons and microglia. We probed ENT, an area affected early in AD pathogenesis, by liquid chromatography-tandem mass spectrometry (LC-MS-MS), and found that the levels of the SPMs maresin 1 (MaR1), protectin D1 (PD1), and resolvin (Rv) D5, were lower in ENT of AD patients as compared to age-matched controls, while levels of the pro-inflammatory prostaglandin D2 (PGD2) were higher in AD. In vitro studies showed that lipoxin A4 (LXA4), MaR1, resolvin D1 (RvD1), and protectin DX (PDX) exerted neuroprotective activity, and that MaR1 and RvD1 down-regulated β-amyloid (Aβ)42-induced inflammation in human microglia. MaR1 exerted a stimulatory effect on microglial uptake of Aβ42. Our findings give further evidence for a disturbance of the resolution pathway in AD, and indicate that stimulating this pathway is a promising treatment strategy for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In vitro and in vivo studies suggested that MaR1 can inhibit inflammation and promote phagocytosis in microglia428,430,431 and improve the cognitive decline in AD mouse model.432”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [428]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Liquid chromatography-tandem mass spectrometry (LC-MS-MS) analysis of lipid mediators in the entorhinal cortex of AD patients revealed the downregulation of SPMs including protectin D1 (PD1), maresin 1 (MaR1) and resolvin (RvD5), and upregulation of PGD2, a proinflammatory lipid mediator, compared with age-matched controls.428”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [428]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Xu, M., Tan, B., Zhou, W., Wei, T., Lai, W., Tan, J., & Dong, J. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12069 · Cited by 51
RetractedAlzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Cytokine-mediated regulation of CXCR4 expression in human neutrophils
Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 4,713
Pro-resolving lipid mediators are leads for resolution physiology
Serhan, C. N. (2014) · Nature · doi:10.1038/nature13479 · Cited by 3,041
Self-citationOxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B. O., Dahlén, S., LINDGREN, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Self-citationBrain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Polyunsaturated fatty acids and their metabolites in brain function and disease
Bazinet, R. P., & Layé, S. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3820 · Cited by 1,694
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Self-citationMcGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367
Cited by
Sorted by citations
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344
Self-citationAge and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
Lipids and Alzheimer’s Disease
Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485
Yin, F. (2023) · The FEBS Journal · doi:10.1111/febs.16344 · Cited by 441
Bioactive Lipids and Chronic Inflammation: Managing the Fire Within
Chiurchiù, V., Leuti, A., & Maccarrone, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00038 · Cited by 427
Layé, S., Nadjar, A., Joffre, C., & Bazinet, R. P. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014092 · Cited by 420
Bioactive lipids, inflammation and chronic diseases
Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 373
Resolution of inflammation: An organizing principle in biology and medicine
Panigrahy, D., Gilligan, M. M., Serhan, C. N., & Kashfi, K. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107879 · Cited by 359
Self-citationFood for thought: how nutrition impacts cognition and emotion
Spencer, S. J., Kőrösi, A., Layé, S., Shukitt‐Hale, B., & Barrientos, R. M. (2017) · npj Science of Food · doi:10.1038/s41538-017-0008-y · Cited by 304
The human microglial HMC3 cell line: where do we stand? A systematic literature review
Russo, C. D., Cappoli, N., Coletta, I., Mezzogori, D., Paciello, F., Pozzoli, G., Navarra, P., & Battaglia, A. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1288-0 · Cited by 271
Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions
Chiang, N., Libreros, S., Norris, P. C., de la Rosa, X., & Serhan, C. N. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129448 · Cited by 259
Self-citationAhmmed, M. K., Ahmmed, F., Tian, H. S., Carne, A., & Bekhit, A. E. A. (2019) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12510 · Cited by 251
Brain docosahexaenoic acid uptake and metabolism
Lacombe, R. J. S., Chouinard‐Watkins, R., & Bazinet, R. P. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.12.004 · Cited by 225
Fatty acid metabolism in the progression and resolution of CNS disorders
Bogie, J. F. J., Haidar, M., Kooij, G., & Hendriks, J. J. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.01.004 · Cited by 167
Francos-Quijorna, I., Santos-Nogueira, E., Gronert, K., Sullivan, A. B., Kopp, M. A., Brommer, B., David, S., Schwab, J. M., & López‐Vales, R. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1395-17.2017 · Cited by 167
Giacobbe, J., Benoiton, B., Zunszain, P., Pariante, C. M., & Borsini, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00122 · Cited by 159
Impact of dietary fats on brain functions
Chianese, R., Coccurello, R., Viggiano, A., Scafuro, M., Fiore, M., Coppola, G., Operto, F. F., Fasano, S., Laye, S., Pierantoni, R., et al. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171017102547 · Cited by 159
N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation
Joffre, C., Rey, C., & Layé, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01022 · Cited by 157
Unsaturated Fatty Acids and Their Immunomodulatory Properties
Coniglio, S. J., Shumskaya, M. A., & Vassiliou, E. K. (2023) · Biology · doi:10.3390/biology12020279 · Cited by 163
Resolution of inflammation during multiple sclerosis
Ruiz, F., Vigne, S., & Pot, C. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00765-0 · Cited by 136
Kooij, G., Troletti, C. D., Leuti, A., Norris, P. C., Riley, I. R., Albanese, M., Ruggieri, S., Libreros, S., van der Pol, S. M. A., Hof, B. V. H., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.219519 · Cited by 123
Self-citationKantarci, A., Aytan, N., Palaska, I., Stephens, D., Crabtree, L., Benincasa, C., Jenkins, B. G., Carreras, I., & Dedeoglu, A. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.11.005 · Cited by 118
Bisicchia, E., Sasso, V., Catanzaro, G., Leuti, A., Besharat, Z. M., Chiacchiarini, M., Molinari, M., Ferretti, E., Viscomi, M. T., & Chiurchiù, V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0889-z · Cited by 125
English, J. T., Norris, P. C., Hodges, R. R., Dartt, D. A., & Serhan, C. N. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.01.004 · Cited by 114
Self-citationRole of dietary fatty acids in microglial polarization in Alzheimer’s disease
Desale, S. E., & Chinnathambi, S. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01742-3 · Cited by 111
Labrousse, V. F., Leyrolle, Q., Amadieu, C., Aubert, A., Séré, A., Coutureau, É., Gregoire, S., Brétillon, L., Pallet, V., Gressèns, P., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.06.004 · Cited by 99
Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review
Whittington, R. A., Planel, E., & Terrando, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01464 · Cited by 93
Dyall, S. C. (2017) · Lipids · doi:10.1007/s11745-017-4292-8 · Cited by 95
Kerdiles, O., Layé, S., & Calon, F. (2017) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2017.09.003 · Cited by 87
Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy
Lee, J. Y., Jin, H. K., & Bae, J.-S. (2020) · BMB Reports · doi:10.5483/bmbrep.2020.53.1.278 · Cited by 80
Role of Resolvins in the Inflammatory Resolution of Neurological Diseases
Li, C., Wu, X., Liu, S., Shen, D., Zhu, J., & Liu, K. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00612 · Cited by 83
Hopperton, K. E., Trépanier, M., Giuliano, V., & Bazinet, R. P. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0721-5 · Cited by 85
Noh, M., Kwon, H. S., Kwon, M., Nahm, M., Jin, H. K., Bae, J., & Kim, S. H. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00867-4 · Cited by 89
Targeted lipidomics reveals activation of resolution pathways in knee osteoarthritis in humans
Jónasdóttir, H. S., Brouwers, H., Kwekkeboom, J., van der Linden, H. M. J., Huizinga, T. W. J., Kloppenburg, M., Toes, R. E. M., Giera, M. A., & Ioan‐Facsinay, A. (2017) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2017.01.018 · Cited by 78
Maresin-1 and Inflammatory Disease
Saito‐Sasaki, N., Sawada, Y., & Nakamura, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031367 · Cited by 78
Yin, P., Wang, X., Wang, S., Wei, Y., Feng, J., & Zhu, M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00466 · Cited by 73
Self-citationn-3 Polyunsaturated Fatty Acids and Their Derivates Reduce Neuroinflammation during Aging
Joffre, C., Dinel, A., Chataigner, M., Pallet, V., & Layé, S. (2020) · Nutrients · doi:10.3390/nu12030647 · Cited by 80
Emre, C., Do, K. V., Jun, B., Hjorth, E., Alcalde, S. G., Kautzmann, M.-A. I., Gordon, W. C., Nilsson, P., Bazan, N. G., & Schultzberg, M. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01216-4 · Cited by 76
Self-citationKetogenic Diet: An Effective Treatment Approach for Neurodegenerative Diseases
Zhang, H., Tao, Y., & Leng, S. X. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220830102628 · Cited by 76
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
Do, K. V., Hjorth, E., Wang, Y., Jun, B., Kautzmann, M.-A. I., Ohshima, M., Eriksdotter, M., Schultzberg, M., & Bazan, N. G. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01216-5 · Cited by 67
Self-citationLipidomics of Bioactive Lipids in Alzheimer’s and Parkinson’s Diseases: Where Are We?
Chiurchiù, V., Tiberi, M., Matteocci, A., Fazio, F., Siffeti, H., Saracini, S., Mercuri, N. B., & Sancesario, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116235 · Cited by 73
Goldwaser, E. L., Acharya, N. K., Sarkar, A., Godsey, G. A., & Nagele, R. G. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160284 · Cited by 64
Serhan, C. N., de la Rosa, X., & Jouvene, C. C. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12871 · Cited by 63
Self-citationThe Role of Eicosanoids in Alzheimer’s Disease
Biringer, R. G. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16142560 · Cited by 65
Cao, Y., Zhao, L.-W., Chen, Z.-X., & Li, S.-H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1430465 · Cited by 65
Can inflammation be resolved in Alzheimer’s disease?
Zhu, M., Wang, X., Sun, L., Schultzberg, M., & Hjorth, E. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418791107 · Cited by 62
Self-citationReceptors for pro‐resolving mediators are increased in Alzheimer's disease brain
Emre, C., Hjorth, E., Bharani, K., Carroll, S., Granholm, A., & Schultzberg, M. (2020) · Brain Pathology · doi:10.1111/bpa.12812 · Cited by 60
Self-citationPonce, J., Ulu, A., Hanson, C., Cameron‐Smith, E., Bertoni, J. M., Wuebker, J., Fisher, A. L., Siu, K., Marmelat, V., Adamec, J., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.780811 · Cited by 59
Recchiuti, A., Mattoscio, D., & Isopi, E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00252 · Cited by 60
Ebright, B., Assante, I., Poblete, R. A., Wang, S., Duro, M. V., Bennett, D. A., Arvanitakis, Z., Louie, S. G., & Yassine, H. N. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-01084-7 · Cited by 56
The Role of Maresins in Inflammatory Pain: Function of Macrophages in Wound Regeneration
Hwang, S.-M., Chung, G., Kim, Y. H., & Park, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235849 · Cited by 58
Emre, C., Arroyo-García, L. E., Do, K. V., Jun, B., Ohshima, M., Alcalde, S. G., Cothern, M. L., Maioli, S., Nilsson, P., Hjorth, E., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03169-3 · Cited by 55
Self-citationSun, Y., Wei, K., Liao, X., Wang, J., Gao, L., & Pang, B. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5580 · Cited by 60
Cederholm, T. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000350 · Cited by 55
N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer’s disease
Lee, J. Y., Han, S. H., Park, M. H., Song, I., Choi, M., Yu, E., Park, C., Kim, H.-J., Kim, S. H., Schuchman, E. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16080-4 · Cited by 53
Valente, M., Dentoni, M., Bellizzi, F., Kuris, F., & Gigli, G. L. (2022) · Molecules · doi:10.3390/molecules27154836 · Cited by 52
Direct and indirect effects of lipids on microglia function
Leyrolle, Q., Layé, S., & Nadjar, A. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134348 · Cited by 50
Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases
Jaén, R. I., Sánchez‐García, S., Fernández‐Velasco, M., Boscá, L., & Prieto, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658840 · Cited by 50
Pro-resolving lipid mediators: Agents of anti-ageing?
Doyle, R., Sadlier, D. M., & Godson, C. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.002 · Cited by 52
Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid
Beyer, M. P., Videla, L. A., Farías, C., & Valenzuela, R. (2023) · Nutrients · doi:10.3390/nu15153317 · Cited by 54
Role of metabolic programming in the modulation of microglia phagocytosis by lipids
Nadjar, A. (2018) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.07.006 · Cited by 49
Bioactive lipids as new class of microglial modulators: When nutrition meets neuroimunology
Nadjar, A., Leyrolle, Q., Joffre, C., & Layé, S. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.07.004 · Cited by 50
Resolution of Inflammation in Neurodegenerative Diseases: The Role of Resolvins
Chamani, S., Bianconi, V., Tasbandi, A., Pirro, M., Barreto, G. E., Jamialahmadi, T., & Sahebkar, A. (2020) · Mediators of Inflammation · doi:10.1155/2020/3267172 · Cited by 44
Modulation of innate immunity of patients with Alzheimer's disease by omega‐3 fatty acids
Fiala, M., Kooij, G., Wagner, K. M., Hammock, B. D., & Pellegrini, M. A. (2017) · The FASEB Journal · doi:10.1096/fj.201700065r · Cited by 44
Perucci, L. O., Sugimoto, M. A., Gomes, K. B., Dusse, L. M. S., Teixeira, M. M., & Sousa, L. P. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1364363 · Cited by 45
Vamecq, J., Andreoletti, P., Kebbaj, R. E., Saih, F.-E., Latruffe, N., Kebbaj, M. S. E., Lizard, G., Nasser, B., & Cherkaoui‐Malki, M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6986984 · Cited by 43
Trojan, E., Bryniarska, N., Leśkiewicz, M., Regulska, M., Chamera, K., Szuster-Głuszczak, M., Leopoldo, M., Lacivita, E., & Basta‐Kaim, A. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191019170244 · Cited by 42
Tajbakhsh, A., Read, M. I., Barreto, G. E., Ávila-Rodriguez, M., Hayat, S. M. G., & Sahebkar, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173873 · Cited by 41
Serhan, C. N., Bäck, M., Chiurchiù, V., Hersberger, M., Mittendorfer, B., Calder, P. C., Waitzberg, D. L., Stoppe, C., Kłęk, S., Martindale, R. G., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202400619r · Cited by 49
Self-citationHan, Y., KyeongJin, L., Saha, A., Han, J., Choi, H., Noh, M., Lee, Y., & Lee, M. (2021) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2021.094 · Cited by 43
Liu, W., Yang, Y.-H., Wang, Y.-C., Chang, W., & Wang, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311012 · Cited by 39
The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer’s Disease
de Wit, N. M., Mol, K., Rodríguez‐Lorenzo, S., de Vries, H. E., & Kooij, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.620348 · Cited by 40
Hooper, C., Barreto, P. D. S., Pahor, M., Weiner, M. W., & Vellas, B. J. (2018) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2017.19 · Cited by 38
Klevebro, S., Juul, S. E., & Wood, T. R. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00533 · Cited by 40
Miyazawa, K., Fukunaga, H., Tatewaki, Y., Takano, Y., Yamamoto, S., Mutoh, T., & Taki, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165783 · Cited by 37
Lipids and brain inflammation in APOE4-associated dementia
Duro, M. V. V., Ebright, B., & Yassine, H. N. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000801 · Cited by 39
The enzymology of human eicosanoid pathways: the lipoxygenase branches
Biringer, R. G. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05698-8 · Cited by 35
RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome
Hamlett, E. D., Hjorth, E., Ledreux, A., Gilmore, A., Schultzberg, M., & Granholm, A. C. (2020) · Glia · doi:10.1002/glia.23779 · Cited by 34
Self-citationHopperton, K. E., Trépanier, M., James, N. C. E., Chouinard‐Watkins, R., & Bazinet, R. P. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.11.002 · Cited by 38
Otoki, Y., Kato, S., Nakagawa, K., Harvey, D. J., Jin, L., Dugger, B. N., & Taha, A. Y. (2021) · NeuroMolecular Medicine · doi:10.1007/s12017-020-08636-w · Cited by 34
Lipoxins in the Nervous System: Brighter Prospects for Neuroprotection
Zhang, J., Li, Z., Fan, M., & Jin, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.781889 · Cited by 35
Maresin 1 attenuates pro‐inflammatory activation induced by β‐amyloid and stimulates its uptake
Wang, Y., Leppert, A., Tan, S., van der Gaag, B., Li, N., Schultzberg, M., & Hjorth, E. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16098 · Cited by 33
Self-citationMiao, Z., Schultzberg, M., Wang, X., & Zhao, Y. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2020.12.037 · Cited by 34
Self-citationSublette, M. E., Daray, F. M., Ganança, L., & Shaikh, S. R. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02322-6 · Cited by 35
Lippestad, M., Hodges, R. R., Utheim, T. P., Serhan, C. N., & Dartt, D. A. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-21914 · Cited by 30
Self-citationDecreased Blood Level of MFSD2a as a Potential Biomarker of Alzheimer’s Disease
Sánchez-Campillo, M., Ruiz-Pastor, M. J., Gázquez, A., Marín-Muñoz, J., Noguera-Perea, F., Ruiz‐Alcaraz, A. J., Manzanares, S., Antúnez, C., & Larqué, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010070 · Cited by 30
Modulations of bioactive lipids and their receptors in postmortem Alzheimer’s disease brains
Kurano, M., Saito, Y., Uranbileg, B., Saigusa, D., Kano, K., Aoki, J., & Yatomi, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1066578 · Cited by 30
The diverse roles of macrophages in metabolic inflammation and its resolution
Ray, A. G., Odum, O., Wiseman, D., & Weinstock, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1147434 · Cited by 33
Engert, L. C., Mullington, J. M., & Haack, M. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.06.018 · Cited by 30
Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases
Shang, P., Zhang, Y., Ma, D., Hao, Y., Wang, X., Xin, M., Zhang, Y., Zhu, M., & Feng, J. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1691525 · Cited by 30
Self-citationInflammatory and Pro-resolving Mediators in Frontotemporal Dementia and Alzheimer’s Disease
Fraga, V. G., Magalhaes, C. A., Loures, C. D. M. G., de Souza, L. C., Guimarães, H. C., Zauli, D. A. G., Ferriani, M. D. G. C., Ferreira, C. N., Caramelli, P., Sousa, L. P., et al. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.09.008 · Cited by 28
Resolution of inflammation: Intervention strategies and future applications
Panezai, J., & Dyke, T. E. V. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116089 · Cited by 30
Fraga, V. G., Ferriani, M. D. G. C., Caramelli, P., Sousa, L. P., & Gomes, K. B. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.07.005 · Cited by 26
Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer’s Disease
Chávez-Castillo, M., Gotera, M. P., Durán, P., Diaz, M. P., Nava, M., Cano, C., Díaz-Camargo, E. A., Cano, G., Cano, R., Rivera-Porras, D., et al. (2025) · Molecules · doi:10.3390/molecules30153057 · Cited by 33
Fair‐Weather Friends: Evidence of Lipoxin Dysregulation in Neurodegeneration
Kim, C., Livne‐Bar, I., Gronert, K., & Sivak, J. M. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201801076 · Cited by 26
Resolvin D1 : A key endogenous inhibitor of neuroinflammation
Roohbakhsh, A., Etemad, L., & Karimi, G. (2022) · BioFactors · doi:10.1002/biof.1891 · Cited by 32
Van, A. L., Sakayori, N., Hachem, M., Belkouch, M., Picq, M., Fourmaux, B., Lagarde, M., Osumi, N., & Bernoud‐Hubac, N. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1139-0 · Cited by 27
Hong, S., Nagayach, A., Lü, Y., Peng, H., Duong, Q.-V., Pham, N. B., Vuong, C. A., & Bazan, N. G. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13726 · Cited by 24
Möller, I., Rodas, G., Villalón, J. M., Rodas, J. A., Angulo, F., Martínez, N., & Vergés, J. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04283-4 · Cited by 25
Metadata
- Authors
- Zhu, M., Wang, X., Hjorth, E., Colas, R. A., Schroeder, L., Granholm, A.-C., Serhan, C. N., & Schultzberg, M.
- Affiliations
- Karolinska Institutet (SE)
- Shanghai Jiao Tong University (CN)
- Brigham and Women's Hospital (US)
- Medical University of South Carolina (US)
- Corresponding author
- Schultzberg, Marianne
- Venue
- Molecular Neurobiology
- Published
- 2015-12-09
- Volume
- 53
- Issue
- 4
- Pages
- 2733-2749
- ISSN
- 0893-7648 (ISSN-L)
- 1559-1182
- PMC
- PMC4824659
- OpenAlex
- W2291813090
- Cited by
- 204
- References
- 90
- Citations by year
- 2026: 14 · 2025: 10 · 2024: 22 · 2023: 21 · 2022: 25 · 2021: 26 · 2020: 20 · 2019: 21 · 2018: 19 · 2017: 20 · 2016: 6
- FWCI
- 14.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- The Swedish Research Council (22743 and 22744)
- The Chinese Scholarship Council
- Swedish Brain Power
- The Knut and Alice Wallenberg Foundation
- Karolinska Institutet research funds
- The Swedish Alzheimer Foundation
- Stiftelsen för Gamla Tjänarinnor
- Gun och Bertil Stohnes Stiftelse
- Barmore Fund
- National Institutes of Health (P01GM095467, GM038765)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, inflammation resolution, specialized pro-resolving mediators, lipid mediators, entorhinal cortex, maresin 1, protectin D1, resolvin D1, lipoxin A4, protectin DX, resolvin D5, prostaglandin D2, microglia, amyloid-beta 42, phagocytosis, neuroprotection, neuroinflammation
- MeSH terms
- Aged, Cell Survival, Chromatography, Liquid, Female, Humans, Lipids, Male, Neurons, Peptide Fragments, Phagocytosis, Phenotype, Postmortem Changes, Amyloid beta-Peptides, Microglia, Entorhinal Cortex, Staurosporine, Cell Line, Tumor, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review